Detalhe da pesquisa
1.
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Am Heart J
; 267: 1-11, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758044
2.
Postpartum weight retention and the early evolution of cardiovascular risk over the first 5 years after pregnancy.
Cardiovasc Diabetol
; 23(1): 101, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500162
3.
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial.
Nephrol Dial Transplant
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323492
4.
Impact of the diagnosis of gestational diabetes on maternal physical activity after pregnancy.
Diabetes Obes Metab
; 26(4): 1207-1215, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116699
5.
Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy.
Diabetologia
; 66(11): 2154-2163, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612415
6.
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.
Circulation
; 145(8): 575-585, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903039
7.
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Circulation
; 145(19): 1460-1470, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394821
8.
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials.
Stroke
; 54(8): 2013-2021, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449424
9.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
; 82(1): 84-96.e1, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889425
10.
The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes.
Cardiovasc Diabetol
; 22(1): 50, 2023 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894921
11.
Baseline determinants of remission of type 2 diabetes in response to short-term insulin-based therapy: The pivotal role of beta-cell function.
Diabetes Obes Metab
; 25(9): 2473-2481, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380623
12.
Determinants of Anishinabeck infant and early childhood growth trajectories in Northwestern Ontario, Canada: a cohort study.
BMC Pediatr
; 23(1): 641, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115010
13.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
N Engl J Med
; 380(24): 2295-2306, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30990260
14.
The ongoing evolution of basal insulin therapy over 100 years and its promise for the future.
Diabetes Obes Metab
; 24 Suppl 1: 17-26, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34532950
15.
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial.
Diabetes Obes Metab
; 24(1): 135-141, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558768
16.
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes.
Diabetes Obes Metab
; 24(6): 1061-1071, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166009
17.
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement.
Diabetologia
; 64(5): 947-953, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492422
18.
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study.
Diabetologia
; 64(6): 1235-1245, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559704
19.
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
Kidney Int
; 99(4): 999-1009, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316282
20.
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
Kidney Int
; 99(3): 750-762, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33181154